Table 3 Imaging and clinical responses of 42 patients (75 MR visits)
| Â | Â | Clinical response | ||||
| Â | Â | Complete response | Partial response | Stable disease | Progressive disease | Total |
RECIST 1.1 | Complete response | 1 | 1 | 0 | 0 | 2 (2.7%) |
Partial response | 11 | 18 | 0 | 0 | 29 (38.7%) | |
Stable disease | 9 | 14 | 0 | 2 | 25 (33.3%) | |
Progressive disease | 1 | 2 | 0 | 16 | 19 (25.3%) | |
Total | 22 (29.3%) | 35 (46.7%) | 0 | 18 (24.0%) | 75 | |
| Â | Â | Clinical response | ||||
| Â | Â | Complete response | Partial response | Stable disease | Progressive disease | Total |
MDA criteria | Complete response | 1 | 1 | 0 | 0 | 2 (2.7%) |
Partial response | 15 | 18 | 0 | 1 | 34 (45.3%) | |
Stable disease | 5 | 14 | 0 | 1 | 20 (26.7%) | |
Progressive disease | 1 | 2 | 0 | 16 | 19 (25.3%) | |
Total | 22 (29.3%) | 35 (46.7%) | 0 | 18 (24.0%) | 75 | |
| Â | Â | Clinical response` | ||||
| Â | Â | Complete response | Partial response | Stable disease | Progressive disease | Total |
MDA-DWI criteria | Complete response | 1 | 1 | 0 | 0 | 2 (2.7%) |
Partial response | 19 | 27 | 0 | 1 | 47 (62.7%) | |
Stable disease | 1 | 5 | 0 | 1 | 7 (9.3%) | |
Progressive disease | 1 | 2 | 0 | 16 | 19 (25.3%) | |
Total | 22 (29.3%) | 35 (46.7%) | 0 | 18 (24.0%) | 75 | |